A recent in vivo study demonstrated that tacrolimus ameliorated skilled motor deficits produced by middle cerebral artery occlusion. 1 Because tacrolimus was reported to have a neuroprotective effect, 2 it has attracted a great deal of attention as a potent agent for treatment of stroke. 3 Its potency is supported by in vitro evidence that tacrolimus showed a remarkable protective effect against excitotoxic neural death in cultured cells. 4, 5 Moreover, tacrolimus has been indicated to have such an intense immunosuppressant property that it has been used for the prevention of allograft rejection. 6 The immunosuppressant property of tacrolimus is initially exerted on leukocytes, especially on T cells. 7 Many in vivo investigations have indicated that tacrolimus ameliorates allograft rejection by inhibiting leukocyte participation and activation. 8 When considering tacrolimus as treatment for stroke, its immunosuppressant property to leukocytes would substantially contribute to a neuroprotective effect on stroke. However, little is known about the effect of tacrolimus on leukocyte dynamics in postischemic tissue, especially in the brain.
Because leukocytes are thought to play a central role in ischemia reperfusion injury, 9 it would be very valuable to investigate leukocyte dynamics in the brain after stroke. 10 But
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only a few techniques allow an investigation of leukocyte dynamics in the postischemic brain: observation from a cranial window with an intravital microscope 11 or a confocal laser scanning microscope. 12, 13 Intravital microscopic observation from a cranial window can visualize leukocyte dynamics only in the pial microcirculation. 11 A confocal laser scanning microscope allows us to evaluate leukocyte movement in the cerebrum, 12 but it can make the optical sectioning of the outer 150 m of the cortex. 13 Accordingly, these methods cannot visualize leukocyte dynamics deep in the cortex or in the major cerebral vessels.
In contrast to the cerebrum, the optic media (which consists of cornea, lens, vitreous, and retina) are so transparent that the retinal microcirculation could be observed noninvasively in vivo. Moreover, the retina belongs to the central nervous system, and the property seen in endothelial cells and neural cells in the retina is reportedly similar to that in the cerebrum. 14 -16 Therefore, investigation of leukocyte dynamics in the postischemic retina would be valuable for the evaluation of leukocyte involvement in the postischemic cerebral injury.
Recently, we have developed the technique of acridine orange digital fluorography. [17] [18] [19] [20] Acridine orange digital fluorography allows us to visualize leukocytes clearly and to evaluate leukocyte dynamics quantitatively in the retinal microcirculation in vivo. Using this technique, we recently have shown that leukocyte dynamics in the postischemic retina, such as leukocyte rolling, adhesion, and accumulation, could be evaluated quantitatively. 21 The purpose of this study was to evaluate quantitatively the inhibitory effects of tacrolimus on leukocyte rolling and on subsequent leukocyte accumulation in vivo in the postischemic retina and the therapeutic efficacy of tacrolimus on ischemia-induced retinal damage.
Materials and Methods

Animal Model
Induction of transient retinal ischemia was reported previously, in which the method described by Stefansson et al, 22 with slight modification, was used. 21, 23 Male pigmented Long-Evans rats (200 to 250 g; nϭ72) were anesthetized with xylazine hydrochloride (4 mg/kg) and ketamine hydrochloride (10 mg/kg). The pupils were dilated with 0.5% tropicamide and 2.5% phenylephrine hydrochloride. After a lateral conjunctival peritomy and disinsertion of the lateral rectus muscle, the optic sheath of the right eye was exposed by blunt dissection. A 6 -0 nylon suture was passed around the optic sheath and tightened until blood flow ceased in all retinal vessels. The absence of perfusion for a 60-minute period was confirmed through an operating microscope, and the suture was removed thereafter. Reperfusion of the vessels was observed through the operating microscope.
Tacrolimus-treated rats were injected intramuscularly with 3.2 mg/kg of tacrolimus at 10 minutes after induction of ischemia; vehicle-treated rats were given the same volume of saline. All experiments were performed in accordance with the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research.
Acridine Orange Digital Fluorography
Acridine orange digital fluorography has been previously described elsewhere. [17] [18] [19] In this technique, a scanning laser ophthalmoscope (Rodenstock Instrument), coupled with a computer-assisted image analysis system, makes continuous high-resolution images of fundus stained by the metachromatic fluorochrome AO (Wako Pure Chemical). The dye emits a green fluorescence when it interacts with DNAs. The spectral properties of AO-DNA complexes are very similar to those of sodium fluorescein, with an excitation maximum at 502 nm and an emission maximum at 522 nm. 24 The argon blue laser was used for the illumination source, with a regular emission filter for fluorescein angiography. Immediately after AO solution was infused intravenously, leukocytes were stained selectively among circulating blood cells. Nuclei of vascular endothelial cells also were stained. The obtained images were recorded on an S-VHS videotape at the video rate of 30 frames/s for further analysis.
Experimental Design
Acridine orange digital fluorography was performed at 4, 12, 24, and 48 hours after reperfusion both in tacrolimus-treated and vehicletreated groups. Nonischemic rats were evaluated as the control. Six different rats were used at each time point in each group.
Immediately before acridine orange digital fluorography, rats were anesthetized with the same agent, and the pupils were dilated. A contact lens was used to retain corneal clarity throughout the experiment. Each rat had a catheter inserted into the tail vein, and was placed on a stereotaxic platform. Body temperature was maintained at 38Ϯ0.5°C throughout the experiment. Arterial blood pressure was monitored with a blood pressure analyzer (IITC) (see the Table) . AO (0.1% solution in saline) was injected continuously through the catheter for 1 minute at a rate of 1 mL/min. The fundus was observed with the scanning laser ophthalmoscope in the 40°f ield for 5 minutes. At 30 minutes after the injection of AO, the fundus was observed again to evaluate leukocytes accumulated in the retinal microcirculation.
After the experiment, the rat was killed with an anesthetic overdose, and the eye was enucleated to determine a calibration factor with which to convert values measured on a computer monitor (in pixels) into real values (in micrometers).
Image Analysis
The video recordings were analyzed with an image analysis system, which has been described in detail elsewhere. [17] [18] [19] In brief, the system consists of a computer equipped with a video digitizer (Radius). The latter digitizes the video image in real time (30 frames/s) to 640 horizontal and 480 vertical pixels with an intensity resolution of 256 steps. We evaluated the diameters of major retinal vessels, the flux of rolling leukocytes along the major retinal veins, the velocity of rolling leukocytes, and the number of leukocytes accumulated in the retinal microcirculation through use of this system. 20, 21 The diameters of major retinal vessels were measured at 1 disk diameter from the center of the optic disk in monochromatic images recorded before AO injection. Each vessel diameter was calculated in pixels as the distance between the half-height points determined separately on each side of the density profile of the vessel image and converted into real values using the calibration factor. The averages of the individual arterial and venous diameters were used as the arterial and venous diameters for each rat.
Rolling leukocytes were defined as leukocytes that moved at a velocity slower than that of free-flowing leukocytes. The number of rolling leukocytes was calculated from the number of cells crossing a fixed area of the vessel at a distance 1 disk diameter from the optic disk center per minute. The flux of rolling leukocytes was defined as the total number of rolling leukocytes along all major veins.
Selected Abbreviations and Acronyms
AO ϭ acridine orange GCL ϭ ganglion cell layer IL ϭ interleukin INL ϭ inner nuclear layer IPL ϭ inner plexiform layer NO ϭ nitric oxide NOS ϭ nitric oxide synthase ONL ϭ outer nuclear layer MABP indicates mean arterial blood pressure; WBC, peripheral leukocyte count. There were no significant differences between vehicle-treated and tacrolimus-treated rats.
Mean Arterial Blood Pressure and Periphereal Leukocyte Count for All Groups
Velocity of rolling leukocytes was calculated as the time required for a leukocyte to travel a given distance along the vessel. The average of at least 10 velocities was defined as the velocity of rolling leukocytes for each rat.
The number of leukocytes accumulated in the retinal microcirculation was evaluated at 30 minutes after AO injection. The number of fluorescent dots in the retina within 8 to 10 areas of 100 pixels square at a distance of 1 disk diameter from the edge of the optic disk was counted. The average number of individual areas was used as the number of leukocytes accumulated in the retinal microcirculation for each rat.
Histological Procedures
Six eyes from 6 rats in tacrolimus-treated, vehicle-treated, and nonoperated control groups were obtained to evaluate the severity of retinal damage. After 7 days of reperfusion, the rats were killed with an anesthetic overdose. The operated eyes were immediately enucleated and fixed in 1.48% formaldehyde and 1% glutaraldehyde in phosphate buffer and in 3.7% formaldehyde afterward. Then the eyes were dehydrated, embedded in paraffin, sectioned with a microtome at 4 m thickness, and stained with hematoxylin and eosin. Each section was cut along the horizontal meridian of the eye through the optic nervehead. Sections were cut perpendicular to the retinal surface. Retinal sections were examined with an optical microscope (ϫ400) to a masking procedure and then digitized by a chargecoupled device camera on a computer monitor.
To quantify the retinal damage induced by ischemia-reperfusion injury, we measured changes in thickness and cell densities of the retina, using the method described by Hughes 25 with a slight modification. 26, 27 The thickness of the IPL, INL, ONL, and the overall retina from outer to inner limiting membrane (OLM-ILM) was measured. The thickness of retinal layers in each section was measured in the retina at a distance of 1.5 mm from the center of the optic nerve head. The value of each retinal thickness was averaged from 10 measurements of 4 sections from each eye. In addition, the number of cell nuclei of 3 retinal layers (GCL, INL, and ONL) was counted in the retina of a 50-m-wide band from both hemispheric sections at a distance of 1.5 mm from the center of the optic nerve head. The value of density of each layer was averaged from measurements of both hemispheres of 4 sections.
Statistical Analysis
All values are meanϮSEM. Student's t test was used to compare 2 groups. ANOVA was used to compare 3 or more conditions, with post hoc comparisons tested using the Fisher protected least significant difference procedure. Differences were considered statistically significant when the probability values were less than 0.05. Figure 1 shows characteristic fundus images of a nonoperated control rat and vehicle-treated rats at various time points after reperfusion. Figure 2 indicates changes of major retinal vessel diameters in control animals and operated rats at various time points after reperfusion. In arteries, significant vasoconstriction occurred immediately after reperfusion (67.7% to 80.5%, PϽ0.05 versus control rats), with subsequent minor vasodilation. Moreover, vasoconstriction in arteries was more remarkable in tacrolimus-treated rats throughout the experiment compared with vehicle-treated rats (Pϭ0.039). Postischemic veins showed significant vasoconstriction at 4 hours after reperfusion (84.0% in tacrolimus-treated rats and 86.2% in vehicle-treated rats, PϽ0.05 versus control rats). In contrast, significant vasodilation occurred and peaked at 24 hours after reperfusion (127% in tacrolimus-treated rats and 131% in vehicle-treated rats, PϽ0.05 versus the values at 4 hours after reperfusion) and subsided at 48 hours after reperfusion. Venous vasodilation in tacrolimus-treated rats was significantly suppressed at all time points after reperfusion compared with that in vehicle-treated rats (Pϭ0.032).
Results
Diameters of Major Retinal Vessels
Rolling Leukocytes
Immediately after AO was infused intravenously, leukocytes were stained selectively among circulating blood cells (Figure 3A) . Among many free-flowing leukocytes, in operated rats some leukocytes were observed slowly rolling along major retinal veins but not along any major retinal arteries throughout the experiments ( Figure 3B and 3C) .
In vehicle-treated rats, a small number of leukocytes was observed rolling along the venous walls at 4 hours after reperfusion. The flux of rolling leukocytes substantially increased and peaked at 12 hours after reperfusion. In tacrolimus-treated rats, leukocyte rolling was significantly inhibited (Pϭ0.001) ( Figure 4A ). The numbers of rolling leukocytes in tacrolimus-treated rats were significantly reduced-by 68.4% (Pϭ0.003), 60.1% (Pϭ0.013), and 48.5% 
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(Pϭ0.026) at 4, 12, and 24 hours after reperfusion, respectively, compared with those in vehicle-treated rats. Figure 4B indicates changes of leukocyte rolling velocity at various time points after reperfusion. The velocity of rolling leukocytes at 12 hours after reperfusion was significantly slower (Pϭ0.001) compared with values from other times. In tacrolimus-treated rats, the velocity of rolling leukocytes was significantly faster than in vehicle-treated rats (Pϭ0.001).
Leukocytes Accumulated in the Retinal Microcirculation
AO easily infiltrates through the vessel wall and diffuses into the retina because of the permeability of the membrane. Accordingly, a few minutes after AO injection was stopped, fluorescence of circulating leukocytes was faint because of the washout. In contrast, leukocytes that accumulated in the retina remained fluorescent for about 2 hours. These leukocytes were recognized as distinct fluorescent dots at 30 minutes after AO injection, although no circulating leukocytes fluoresced ( Figure 5 ). Figure 6 indicates changes in numbers of leukocytes accumulated in the retinal microcirculation in both groups. In vehicle-treated rats, few leukocytes could be recognized in the control animals, while accumulated leukocytes began to increase with time after reperfusion and peaked at 24 hours after reperfusion. The number of accumulated leukocytes significantly decreased in tacrolimus-treated rats (Pϭ0.0001). The numbers of accumulated leukocytes were reduced by 35.6% (Pϭ0.019) and 61.6% (Pϭ0.0001) at 12 Leukocytes in the capillaries (arrows) moved slowly, making brief stops; leukocytes in the veins (arrowheads) moved at a higher velocity. B, Among free-flowing leukocytes, many rolling leukocytes were observed along the major retinal veins (arrowheads). No rolling leukocytes were seen along the major retinal arteries. Some leukocytes adhered to the venous wall (arrows). C, Two leukocytes were observed rolling along the venous wall (arrowheads), and 1 leukocyte was adhered to the venous wall (arrow). 
Retinal Damage
Histological examination showed the destruction of retinal structures and the decrease of retinal thickness in operated rats whether they were treated with tacrolimus or not ( Figure  7 ). The decrease in retinal thickness and damage of retinal cells were more severe in the inner retina, with less obvious changes in the outer retina. Although retinal thickness was reduced both in tacrolimus-treated and vehicle-treated rats, each retinal layer was significantly preserved in tacrolimustreated rats compared with vehicle-treated rats (Pϭ0.0001). Moreover, cell density of each retinal layer showed that retinal cells were lower in vehicle-treated rats than in tacrolimus-treated rats (Pϭ0.023). The protective effect was more substantial in the inner retina. The thicknesses of INL and IPL in rats treated with tacrolimus were 18.1Ϯ2.1 and 16.6Ϯ2.1 m, which was 208% (Pϭ0.0007) and 319% (Pϭ0.0002) of that in vehicle-treated rats (Figure 7 ). In addition, the cell density of GCL in rats administered tacrolimus was 6.6Ϯ0.3 per 50-m-wide band, which was about 2.6 times as many as that in vehicle-treated rats (Pϭ0.0001).
Discussion
In this study, we clearly visualized and quantitatively evaluated leukocyte rolling along the retinal vessels and leukocyte accumulation in the retina after transient retinal ischemia in vivo. Increasing amounts of evidence had indicated that leukocytes play a central role in postischemic neural damage in the brain. 10, 28, 29 Plugged leukocytes have been suggested to contribute to the no-reflow phenomenon. 28 In addition, accumulated leukocytes have been shown to cause tissue injury by producing superoxide radicals 30 and various kinds of inflammatory cytokines. 31 Recently, from experiments investigating leukocyte adhesion to the vascular endothelium, leukocyte recruitment to the inflammatory region has been shown to be mediated through a multistep process. 32 Each process is mediated with distinct adhesion molecules and regulated elaborately. 33 Therefore, it would be very valuable to investigate leukocyte dynamics in the cerebrum after transient ischemia. 10, 28, 29, 34 Unfortunately, only a few techniques allow us to investigate the cerebral microcirculation. [11] [12] [13] With increased spatial resolution and depth penetration, confocal laser scanning microscopy permits the evaluation of leukocyte dynamics in the microcirculation of the pia mater and the outer layers of the cerebral cortex. 12 Surrounded by the cranium, however, a cranial window is a prerequisite to observe the cerebral microcirculation in vivo. In contrast, acridine orange digital fluorography is a noninvasive technique, [17] [18] [19] [20] except for when retinal ischemia is induced. 21 In this technique, a scanning laser ophthalmoscope makes continuous, high-resolution images of leukocytes stained by a metachromatic fluorochrome of acridine orange at the rate of 30 frames/s. An image analysis system digitizes the video images to 640 horizontal and 480 vertical pixels with an intensity resolution of 256 steps. While ischemic induction entails a minor surgical preparation, it does not invade the inner structures of the eyeball. [21] [22] [23] Preliminary experiments revealed that sham-operated rats, which were subject to the same operation except tightening of the suture, showed no differences in the retinal microcirculation compared with nonoperated control rats.
We investigated the effects of administering tacrolimus on the leukocyte dynamics and neural damage in the postischemic retina. Dirnagl et al 12 have previously reported quantitative evaluation of leukocyte dynamics at the early phase of the postischemic brain. A histological study by Zhang et al 10 demonstrated that neutrophil accumulation in the rat cerebrum after 2 hours of ischemia peaked at 24 to 48 hours after reperfusion. Similarly, we have reported previously that leukocyte rolling and accumulation peaked at 12 and 24 hours after reperfusion, respectively, in the retina subjected to 60 minutes of ischemia. 21 Therefore, prolonged evaluation should be performed to evaluate the inhibitory effect of agents on leukocyte dynamics after transient ischemia.
Previous studies have indicated that tacrolimus is a potent neuroprotectant in focal and global cerebral ischemia, 1,3 of which neuroprotective mechanisms remain unclear. Tacrolimus-forming complex with immunophilin inhibits a calcium/ calmodulin-dependent phosphatase calcineurin. 35 Tacrolimus has been reported to inhibit the calcinulin-induced dephosphorylation and activation of neural NOS and to reduce N-methyl-D-aspartate-mediated neurotoxicity. 4, 5 Furthermore, it has recently been reported that calcineurin-induced dephosphorylation involved in Ca 2ϩ -triggered apoptosis 36 and that tacrolimus may be neuroprotective against delayed neural death by inhibiting Ca 2ϩ -mediated cell death. 3 In addition to these neuroprotective properties, calcineurin inactivation contributes to IL-2 inhibition, interferon gamma expression, and subsequent T-cell proliferation. 37 Furthermore, the transcription factor NF-B, which induces several proinflammatory cytokines, is shown to be inhibited by calcineurin inactivation. 38, 39 An increased expression of proinflammatory cytokines such as IL-1, IL-2, TNF-␣, and interferon gamma has been found after stroke. 40 Many in vitro studies have shown that stimulation with these inflammatory cytokines upregulates the expression of adhesion molecules, such as intercellular adhesion molecule (ICAM)-1, 41 and selectins. 42 Treatment with tacrolimus at 10 minutes after induction of ischemic insult significantly inhibited leukocyte rolling along the retinal veins, moreover, it significantly reduced leukocyte accumulation in the postischemic retina. Tacrolimus administration reduced the maximum number of rolling leukocytes at 12 hours after reperfusion by 60.1%. Subsequent leukocyte accumulation in the retina was reduced to 38.4% at 24 hours after reperfusion. In a histological study in the liver, tacrolimus treatment significantly suppressed expression of ICAM-1 at 12 hours after reperfusion. 8 Immunosuppressant properties would account for a reduction of leukocyte accumulation and the suppression of adhesion molecule expression.
Histological sections demonstrated ischemia-induced tissue damage in operated rats, which was obvious in the inner retina. Histological results in this study showed the protective effect of tacrolimus on neural cell damage after transient ischemia. Indeed, suppression of excitotoxic neural cell death or apoptosis derived from calcineurin inactivation would contribute to this neuroprotective effect. 4, 5 However, in addition to neural cell death induced by ischemic insult accumulated leukocytes would be involved in postischemic tissue injury by blockage of blood flow 28 or by the production of reactive oxygen species 30 and proinflammatory cytokines that accelerate the inflammation. 31 Tacrolimus might attenuate retinal damage in part through reductions of leukocyte accumulation and activation. 8, 9 It has been reported that immunosuppression by sublethal whole body X-irradiation resulted in a significant reduction of brain edema and leukopenia after middle cerebral artery occlusion. 34 Furthermore, leukopenia induced by an anticancer drug has been reported to reduce infarct volumes after transient cerebral ischemia. 29 Although this study did not show that tacrolimus treatment suppressed leukocyte activation, leukocyte accumulation after transient ischemia was significantly ameliorated with tacrolimus treatment. This amelioration would partially contribute to the neuroprotection seen after transient ischemia.
In the present study, as Figure 2 shows, significant vasoconstriction and subsequent vasodilation occurred. Vascular endothelium is a main source of relaxing (eg, NO) and contracting (eg, endothelin) factors, and accumulated leukocytes produce a large amount of NO. 43, 44 The interactions between these factors mediate the vascular tone. 45 We have reported previously 21 that the imbalance may contribute to remarkable vasoconstriction and subsequent vasodilation. In this study, tacrolimus administration caused vasoconstriction both arteries and veins throughout the experiment. Inactivation of neural NOS, as mentioned above, 4 would partially contribute to vasoconstriction. In addition, tacrolimus treatment reduced the number of accumulated leukocytes, 8, 9 which produced a large amount of NO. 43, 44 Furthermore, tacrolimus has also been reported to suppress the production of the inducible NOS in cultured macrophages. 46 In conclusion, leukocyte recruitment to the inflammatory region is mediated through a multistep process. 32, 33 While accumulated leukocytes contribute to host protection, they are also involved in postischemic tissue injury. 9 The present study demonstrated the inhibitory effect of tacrolimus on leukocyte rolling and accumulation and subsequent tissue injury. Our method will allow us to evaluate quantitatively the effectiveness of therapies involving leukocyte participation in the retina and will help us to estimate leukocyte involvement in neural damage in the brain after transient ischemia.
Editorial Comment
The immunosuppressant drugs cyclosporin A, FK506 (tacrolimus), and rapamyocin have revolutionized the field of organ transplantation. These agents bind to small proteins termed immunophilins. 1 For immune suppression, the drugimmunophilin complex inhibits the calcium-dependent serine/threonine protein phosphatase calcineurin. Inhibition of calcineurin prevents dephosphorylation of the nuclear factor of activated T cells, preventing its entry into the nucleus and thereby inhibiting initiation of interleukin-2 transcription.
1 Activation and growth of T cells is inhibited. In addition to inhibiting calcineurin activity, immunophilins have a wide range of intracellular protein targets that can mediate responses other than immunosuppression.
Recently, cyclosporin-A and FK506 have come to the attention of the neuroscience community because of their unique and powerful neuroprotective and neuroregenerative properties.
2,3 FK506 has been shown to be neuroprotective in a variety of models of cerebral ischemia, including both focal and global ischemia, as well as transient and permanent ischemia. Cyclosporin has also been shown to be neuroprotective, although at higher doses than FK506. In vitro, in primary cortical cultures the neuroprotection provided by FK506 against excitotoxicity is mediated in part by preventing dephosphorylation and activation of neuronal NOS by calcineurin. It is proposed that FK506 is neuroprotective after cerebral ischemic insult through inhibition of the catalytic activity of neuronal NOS. 2, 3 However, recent studies 4 show that FK506 does not protect against the excitotoxins quinolinate, NMDA, or AMPA when injected intraparenchamaly in vivo, suggesting that the mechanism of neuroprotection elicited by FK506 after cerebral ischemic insult may occur by mechanisms other than inhibition of neuronal NOS.
In the accompanying article, Tsujikawa and colleagues make a unique observation and present a novel hypothesis for a potential mechanism for the neuroprotection elicited by FK506. In the study the authors induce retinal ischemia by temporarily ligating the optic sheath. In animals treated with FK506, the total number of rolling leukocytes is markedly reduced. In addition, the velocity of rolling leukocytes is significantly faster in FK506-treated animals. The net result is a reduction of leukocyte accumulation following reperfusion. The reduction in leukocyte accumulation correlates with the degree of neuroprotection elicited by FK506 in this temporary ischemic insult model in the retina. These data suggest that one mechanism of FK506-mediated neuroprotection in cerebral ischemic injury is through its immunosuppressant activities on leukocyte activation and entry into postischemic tissue. FK506 has also been shown to suppress the induction of immunologic NOS in cultured macrophages. Iadecola and colleagues 5 have shown that immunologic NOS induction plays a critical role in late-stage neurological damage following ischemic insult. Therefore, the actions of FK506 in suppressing multiple components of the immune system may contribute significantly to its neuroprotective effects after cerebral ischemic insult. These data confirm and extend the usefulness of FK506 or like agents, for potential therapy in the treatment of stroke.
